Skip to main content
PLOS Medicine logoLink to PLOS Medicine
. 2025 Feb 4;22(2):e1004537. doi: 10.1371/journal.pmed.1004537

Effects of X-ray–based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial

Belinda J Lawford 1,*, Kim L Bennell 1, Dan Ewald 2, Peixuan Li 3,4, Anurika De Silva 3,4, Jesse Pardo 1, Barbara Capewell 5, Michelle Hall 6, Travis Haber 1, Thorlene Egerton 1, Stephanie Filbay 1, Fiona Dobson 1, Rana S Hinman 1
Editor: Christelle Nguyen7
PMCID: PMC11838874  PMID: 39903790

Abstract

Background

Although X-rays are not recommended for routine diagnosis of osteoarthritis (OA), clinicians and patients often use or expect X-rays. We evaluated whether: (i) a radiographic diagnosis and explanation of knee OA influences patient beliefs about management, compared to a clinical diagnosis and explanation that does not involve X-rays; and (ii) showing the patient their X-ray images when explaining radiographic report findings influences beliefs, compared to not showing X-ray images.

Methods and findings

This was a 3-arm randomised controlled trial conducted between May 23, 2024 and May 28, 2024 as a single exposure (no follow-up) online survey. A total of 617 people aged ≥45 years, with and without chronic knee pain, were recruited from the Australian-wide community. Participants were presented with a hypothetical scenario where their knee was painful for 6 months and they had made an appointment with a general practitioner (primary care physician). Participants were randomly allocated to one of 3 groups where they watched a 2-min video of the general practitioner providing them with either: (i) clinical explanation of knee OA (no X-rays); (ii) radiographic explanation (not showing X-ray images); or (iii) radiographic explanation (showing X-ray images). Primary comparisons were: (i) clinical explanation (no X-rays) versus radiographic explanation (showing X-ray images); and (ii) radiographic explanation (not showing X-ray images) versus radiographic explanation (showing X-ray images). Primary outcomes were perceived (i) necessity of joint replacement surgery; and (ii) helpfulness of exercise and physical activity, both measured on 11-point numeric rating scales (NRS) ranging 0 to 10.

Compared to clinical explanation (no X-rays), those who received radiographic explanation (showing X-ray images) believed surgery was more necessary (mean 3.3 [standard deviation: 2.7] versus 4.5 [2.7], respectively; mean difference 1.1 [Bonferroni-adjusted 95% confidence interval: 0.5, 1.8]), but there were no differences in beliefs about the helpfulness of exercise and physical activity (mean 7.9 [standard deviation: 1.9] versus 7.5 [2.2], respectively; mean difference −0.4 [Bonferroni-adjusted 95% confidence interval: −0.9, 0.1]). There were no differences in beliefs between radiographic explanation with and without showing X-ray images (for beliefs about necessity of surgery: mean 4.5 [standard deviation: 2.7] versus 3.9 [2.6], respectively; mean difference 0.5 [Bonferroni-adjusted 95% confidence interval: −0.1, 1.2]; for beliefs about helpfulness of exercise and physical activity: mean 7.5 [standard deviation: 2.2] versus 7.7 [2.0], respectively; mean difference −0.2 [Bonferroni-adjusted 95% confidence interval: −0.7, 0.3]). Limitations of our study included the fact that participants were responding to a hypothetical scenario, and so findings may not necessarily translate to real-world clinical situations, and that it is unclear whether effects would impact subsequent OA management behaviours.

Conclusions

An X-ray–based diagnosis and explanation of knee OA may have potentially undesirable effects on people’s beliefs about management.

Trial registration

ACTRN12624000622505.

Author summary

Why was this study done?

  • Uptake of exercise and physical activity among people with osteoarthritis (OA) is low, and use of joint replacement surgery—recommended only for the minority of people with end-stage disease or whose symptoms cannot be managed adequately nonsurgically—is inappropriately high.

  • Although radiographic imaging is not recommended for routine diagnosis of OA, many primary healthcare providers globally still rely on X-rays to diagnose OA.

  • We aimed to provide, to our knowledge, the first empirical evidence from a randomised controlled trial to determine if use of X-rays to diagnose and explain OA influences people’s beliefs about OA management.

What did the researchers do and find?

  • This was a 3-arm randomised controlled trial involving 617 people who were presented with a hypothetical scenario (that their knee was painful and they had made an appointment with a general practitioner) before being randomly allocated to one of 3 groups where the general practitioner provides them with either: (i) clinical explanation of knee OA (no X-rays); (ii) radiographic explanation (not showing X-ray images); or (iii) radiographic explanation (showing X-ray images).

  • We found that using X-rays increased participant beliefs that joint replacement surgery was necessary, but made no difference to beliefs about the helpfulness of exercise and physical activity.

  • We also found that there were no differences in beliefs when explaining radiographic report findings with and without showing the X-ray images.

What do these findings mean?

  • Our work provides, to our knowledge, the first causal evidence that using X-rays rather than a clinical approach to diagnose and explain knee OA can have potentially undesirable impacts on patient beliefs about knee OA.

  • Changing clinical practice around use of X-rays will require a substantial shift in long-held beliefs and habits and our findings are a first step by showing use of X-rays to diagnose knee OA causally impacts patient beliefs.

  • Although many outcomes met or exceeded our a priori minimal 1.0-unit difference immediately after watching the videos, it is unclear whether effects on patient beliefs would impact subsequent OA management behaviours.

Introduction

Knee osteoarthritis (OA) is a leading cause of pain and physical disability worldwide [1,2]. As there is no cure, engagement in long-term self-management of symptoms is advocated, with exercise and physical activity recommended as core first-line approaches for all people with knee OA [36]. However, uptake of exercise and physical activity among people with OA is low, and use of joint replacement surgery—recommended only for the minority of people with end-stage disease or whose symptoms cannot be managed adequately nonsurgically—is inappropriately high [7,8]. Over 1.2 million joint replacements are performed annually in the United States, incurring an estimated $USD20 billion in healthcare costs [9,10]. As joint replacement surgery rates are projected to increase [11,12], strategies to reduce overuse of surgery are needed.

One potential driver of low uptake of nonsurgical treatments, and overuse of joint replacement surgery, is inaccurate public beliefs about OA [13]. As OA is characterised by pain and physical dysfunction [6,14], people with OA often assume their symptoms stem from joint structural changes [15]. However, research shows that joint structural changes are poorly correlated with pain and physical dysfunction, and do not necessarily predict prognosis of symptoms [14,16,17].

Accordingly, radiographic imaging is not recommended for routine diagnosis of OA [14,16,18], and instead, a clinical diagnosis is advocated based on age and symptom presentation [6]. Despite this, many primary healthcare providers globally still rely on X-rays to diagnose OA [8,19,20] and people with musculoskeletal conditions, including OA, expect imaging as part of their clinical care [2123]. Qualitative studies suggest that, when people with OA are shown X-rays, they believe they need to protect their joint from further damage [21,24], and therefore, may be less willing to engage in first-line nonsurgical care like exercise. However, no empirical evidence from randomised controlled trials (RCTs) exists to determine if use of X-rays to diagnose and explain OA influences people’s beliefs about OA management. Our primary aims were to evaluate whether: (i) a radiographic diagnosis and explanation of knee OA influences patient beliefs about OA management, compared to a clinical diagnosis and explanation that does not involve X-rays; and (ii) showing the patient X-ray images when explaining radiographic report findings influences beliefs, compared to not showing X-rays.

Methods

Study design and participants

This was an online 3-arm RCT using a single exposure (no follow-up). Given the practical challenges of identifying and recruiting people when they first present to care seeking a diagnosis for chronic knee pain, we used a hypothetical scenario approach. The trial was prospectively registered (Australian New Zealand Clinical Trials Registry #12624000622505 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=387341&isReview=true) and the protocol can be found in S1 Appendix. The Institutional Human Research Ethics Committee approved the study and participants provided informed consent. This study is reported as per CONSORT guidelines [25] (S2 Appendix).

Participants were recruited from across Australia (in any State or Territory) via a consumer network of people who self-nominated to participate in digital survey-based research (Cint Pty Ltd). Participants receive a small financial incentive (approximately $2.55 AUD for completion of a 15- to 20-min survey) from Cint to compensate them for their time and participation. Incentives were only provided after completing the entire survey to the end. Participants were eligible if they: (i) lived in Australia; (ii) were aged ≥45 years (to reflect clinical criteria for OA [6]); (iii) had never consulted a clinician for chronic knee pain; and (iv) were able to read and understand English. Based on similar studies [2629], we recruited an equal number of people who had, or had not, experienced activity-related knee pain over the prior 3 months. People with and without knee pain were included to simulate the situation of someone without a prior diagnosis of knee OA, and with minimal preconceived knowledge about OA and its treatment, presenting to their general practitioner for the first time. This also allowed us to conduct an exploratory analysis to determine if lived experience of knee pain had a treatment-moderating effect on primary outcomes.

Randomisation and masking

Participants were randomised (1:1:1 ratio, stratified by whether or not they had knee pain) to one of 3 groups using the randomiser function in Qualtrics set to “evenly present elements.” Randomisation order was unknown to researchers. Although participants (who were the assessors as outcomes were self-reported) were unblinded to their allocated intervention, limited disclosure blinded them to the alternate intervention groups. Participants were informed that the trial compared different ways of diagnosing OA, but we did not disclose specific intervention components or study hypotheses. The statistical analysis plan was completed while biostatisticians were blinded to group allocation and published online (https://healthsciences.unimelb.edu.au/departments/physiotherapy/chesm/research-overview/knee-osteoarthritis-diagnosis-trial) and in S3 Appendix.

Procedures

The trial was delivered via online survey software (Qualtrics, Utah, United States of America). After confirming eligibility, participants completed demographic questions (S4 Appendix). They were then asked to consider a hypothetical scenario where their knee had been painful for 6 months and they had made an appointment with a general practitioner (GP; primary care physician) to determine what was wrong (S5 Appendix). Participants were then randomised to one of 3 groups where they watched a ~2-min video of a GP (author DE, who featured in all 3 videos) providing them with a hypothetical: (i) clinical explanation (no X-rays); (ii) radiographic explanation (not showing X-ray images); or (iii) radiographic explanation (showing X-ray images). The hypothetical scenario and all video scripts (Table 1) were created by the researchers (including BC, a consumer with lived experience of knee OA, and DE, a practicing GP) to ensure they reflected typical clinical encounters. Videos were filmed by the researchers in DE’s consulting room. Participants were required to confirm (via checkbox) that they had watched the whole video before completing outcome measures. Videos can be found in S1, S2 and S3 Videos.

Table 1. Video scripts for each of the 3 groups.

Group Clinical explanation (no X-rays) Radiographic explanation (not showing X-ray images) Radiographic explanation (showing X-ray images)
Diagnosis and explanation The most common cause of knee pain in people aged 45 and over is osteoarthritis. Based on your age and the nature of your symptoms, such as having pain with activity like you have described, I think osteoarthritis is the cause of your knee pain. Special tests—such as an X-ray—are not recommended unless we need to rule out another cause of your knee pain. We would only do that if you had unusual symptoms—which you do not have. Also, X-rays do not tell us what will happen with your knee in the future, and we can recommend treatments for you without needing an X-ray. X-rays also expose you to radiation, and it is best to minimise your exposure. “It sounds like you could have knee osteoarthritis—I’m going to send you for X-rays of your knee to confirm what is going on in your joint.”

“I have the report from the X-rays of your knee, which show you do have osteoarthritis, like I suspected. The report states that, in your painful knee, there is reduction in the joint space—which means that the area of the knee joint between the bones is narrower, showing that the cartilage is thinner. The report also states that there are osteophytes—or bony spurs—that are growing around the edges of the joint.
“It sounds like you could have knee osteoarthritis—I’m going to send you for X-rays of your knee to confirm what is going on in your joint.”

“Here are the X-rays of your knee (Image A*), which show you do have osteoarthritis, like I suspected. As you can see here (Image B*), this is your normal knee—you can see the nice space between the bones in your joint indicating healthy cartilage. This (Image C*) is your painful knee, which shows you have osteoarthritis. This area of the knee joint between the bones is narrower, showing where the cartilage is thinner. Over here (Image D*), you can see some osteophytes—or bony spurs—that are growing around the edges of the joint.
Information about prognosis and treatment (provided to ALL groups) Osteoarthritis is a condition of the whole knee, including surrounding cartilage, bones, ligaments, and muscles. Initially, changes occur to some of the structures in the knee. This may be due to previous injuries, genetics, or the type of work you have done. The body will then try to repair these changes. While these repair processes can lead to further joint changes, they often keep the knee working normally. Some people have lots of changes in their knee joint, but this does not necessarily mean they have more knee pain. For most people, osteoarthritis will not get progressively worse. In fact, only about a third of people will get worse over time. There are treatments that can provide pain relief and allow you to get on with your life. Usually, treatment includes an exercise programme tailored to your condition and ability, medicines like paracetamol or nonsteroidal anti-inflammatory drugs, and weight loss if necessary. Some people may need joint replacement surgery if those treatments are not effective. I am sure you have many questions about your knee pain after hearing all that. I am happy to answer any questions you have.

* X-ray images shown in S10 Appendix.

Videos shown in S1, S2 and S3 Videos.

Clinical explanation (no X-rays)

The GP provided a clinical diagnosis and explanation of OA based on age (≥45 years) and nature of symptoms (activity-related joint pain and either no morning stiffness or morning stiffness that lasts no longer than 30 min), as recommended by the National Institute for Health and Care Excellence guidelines [6]. The GP then provided an evidence-based explanation of what OA is, its prognosis, and how it can be managed (adapted from Arthritis Australia website information [30]). The video was 1 min and 46 s in length.

Radiographic explanation (not showing X-ray images)

The GP told the participant that they might have OA and that an x-ray was needed for confirmation. Participants were asked to imagine that they had gone to get an X-ray before returning to the GP for the results. The GP provided a summary explanation of the X-ray report (without showing the participant the X-ray images), including non-emotive, objective lay descriptions about the X-ray findings of narrowed joint space and osteophytes. The GP then explained what OA is, its prognosis, and how it can be managed using the exact same script as in the clinical explanation (no X-rays) group. The video was 1 min and 52 s in length.

Radiographic explanation (showing X-ray images)

The video in this group was almost identical to the radiographic explanation (not showing X-ray images) group, except that participants were shown the X-ray images while the GP provided the explanation of the findings. The GP then provided an explanation about what OA is and how it can be managed using the exact same script as for the other 2 groups. This video was 1 min and 58 s in length.

Outcomes

Bespoke outcome measures (S6 Appendix) were adapted from our similar online RCTs evaluating information effects on patient beliefs [28,29,31]. Primary outcomes were belief about the necessity of joint replacement surgery (“Based on the video you have just watched, do you think joint replacement surgery (to replace the affected joint with an artificial joint) would be necessary for your hypothetical knee osteoarthritis at some stage?”) and helpfulness of exercise and physical activity (“Based on the video you have just watched, do you think exercise and physical activity would be helpful to manage your hypothetical knee osteoarthritis?”), each rated on an 11-point numeric rating scale (NRS) ranging from 0 = “definitely not necessary/helpful” to 10 = “definitely necessary/helpful.”

Secondary outcomes (S6 Appendix) included beliefs about the helpfulness of medication in managing knee OA, beliefs that exercise and physical activity would damage the knee, level of concern that their hypothetical knee OA would get worse in the future, and fear of movement (Brief Fear of Movement Scale [32]). We evaluated perceptions about the helpfulness of different healthcare providers, including orthopaedic surgeons, rheumatologists, and physiotherapists. Finally, participants were asked how satisfied they were with the hypothetical GP consultation and the information provided and their confidence in the accuracy of the diagnosis that they received.

Process measures

We collected data from Qualtrics that measured the time (in seconds) that participants spent on the survey page with the video. Participants indicated (yes/no) whether the video audio and visual quality was sufficient for them to watch and understand.

Sample size

A sample of 609 (203 per group) was required to detect a minimum difference of 1.0 NRS units between groups in each primary outcome with 80% power and a two-sided alpha of 0.0125 (conservative Bonferroni correction for 2 primary outcomes and 2 primary pair-wise comparisons), assuming a between-participant standard deviation (SD) of 3.0 [28] and no attrition [31]. As there is no established minimal important difference for either primary outcome, we chose to detect a minimum difference of 1.0 unit, which corresponds to 10% of the maximum score and was used in similar trials in OA and low back pain [28,29,31,33].

Statistical analysis

Our primary comparisons were: (i) clinical explanation (no X-rays) versus radiographic explanation (showing X-ray images); and (2) radiographic explanation (not showing X-ray images) versus radiographic explanation (showing X-ray images). Our secondary comparison was clinical explanation (no X-rays) versus radiographic explanation (not showing X-ray images).

Data were analysed in Stata version 17.0 [34]. As <5% of data for each primary outcome was missing, multiple imputation was not applied, and analyses were performed on complete case data. Separate linear regression models were used to compare post-intervention scores between groups for each primary and secondary outcome. Regression assumptions, including those of linearity and homoscedasticity, were assessed using standard diagnostic plots. All analysis models were adjusted for the stratification factor lived experience of knee pain.

We interpreted each outcome by examining the estimated between-group mean differences, using two-sided 95% CIs and p-values (Bonferroni-adjusted for primary outcomes across primary comparisons), reported in accordance with recommendations of the American Statistical Association [35].

To explore whether lived experience of knee pain moderated intervention effects, separate linear regression models for each primary outcome were fitted with terms included for group, presence/absence of recent knee pain, and an interaction between the two.

Results

From the 1,372 people screened for eligibility, we enrolled 617 participants between May 23 and May 28, 2024 (Fig 1). Major reasons for exclusion were previously having consulted a clinician for knee pain (n = 523, 36%), discontinuing the survey before randomisation (n = 152, 20%), or not consenting to participate (n = 37, 5%). Characteristics of participants were similar between groups (Table 2). There were no differences between participants who did and did not complete primary outcomes (S7 Appendix).

Fig 1. Participant flow through the trial.

Fig 1

Table 2. Baseline characteristics of participants by group, reported as mean (standard deviation) unless otherwise stated.

Clinical explanation (no X-rays) Radiographic explanation (not showing X-ray images) Radiographic explanation (showing X-ray images)
[N = 208] [N = 203] [N = 206]
Age (years), median (IQR) 60.0 (50.0–67.0) 61.0 (51.0–69.0) 59.0 (50.0–68.0)
Gender, N (%)
 Male 89 (43) 89 (44) 97 (47)
 Female 118 (57) 114 (56) 109 (53)
 Transgender male 1 (<1) 0 (0) 0 (0)
Ethnicity, N (%)
 Australian/New Zealand 148 (71) 137 (67) 145 (70)
 Aboriginal and Torres Strait Islander 5 (2) 2 (1) 2 (1)
 European 36 (17) 40 (20) 35 (17)
 Asian 9 (4) 14 (7) 14 (7)
 Other Oceania 1 (1) 0 (0) 1 (1)
 North African and Middle Eastern 2 (1) 2 (1) 2 (1)
 Sub-Saharan Africa 0 (0) 0 (0) 2 (1)
 North American 2 (1) 3 (1) 1 (<1)
 South American 1 (<1) 2 (1) 0 (0)
 Other 3 (1) 3 (1) 3 (1)
 Prefer not to answer 1 (<1) 0 (0) 1 (<1)
State/territory, N (%)
 Australian Capital Territory 3 (1) 2 (1) 3 (1)
 New South Wales 57 (27) 52 (26) 63 (31)
 Northern Territory 2 (1) 1 (<1) 1 (<1)
 Queensland 52 (25) 43 (21) 44 (21)
 South Australia 21 (10) 19 (9) 14 (7)
 Tasmania 5 (2) 4 (2) 6 (3)
 Victoria 52 (25) 69 (34) 53 (26)
 Western Australia 16 (8) 13 (6) 22 (11)
Height (m) 1.7 (0.1) 1.7 (0.1) 1.7 (0.1)
Weight (kg) 78.8 (19.1) 78.0 (17.7) 80.7 (20.3)
Body mass index (kg/m2) 27.8 (6.5) 28.1 (7.8) 28.7 (7.5)
Highest education level, N (%)
 Primary school 3 (1) 3 (1) 3 (1)
 Secondary school 76 (37) 63 (31) 65 (32)
 Trade or trade certificate 49 (24) 49 (24) 48 (23)
 University or tertiary institute degree 65 (31) 65 (32) 75 (36)
 Higher university degree (e.g. Masters, PhD) 15 (7) 23 (11) 14 (7)
 Do not know/unsure 0 (0) 0 (0) 1 (<1)
Financial situation, N (%)
 Find it a strain to get by from week to week 44 (21) 22 (11) 21 (10)
 Have to be careful with money 81 (39) 87 (43) 83 (40)
 Able to manage without much difficulty 49 (24) 59 (29) 52 (25)
 Quite comfortably off 28 (13) 24 (12) 34 (17)
 Very comfortably off 6 (3) 9 (4) 14 (7)
 Prefer not to answer 0 (0) 2 (1) 2 (1)
Participation in regular exercise/physical activity, N (%)
 None 57 (27) 65 (32) 56 (27)
 Yes, 1 time per week 21 (10) 23 (11) 23 (11)
 Yes, 2–3 times per week 52 (25) 63 (31) 63 (31)
 Yes, 4–5 times per week 52 (25) 35 (17) 37 (18)
 Yes, 6+ times per week 26 (12) 17 (8) 27 (13)
Activity-related knee pain in the last 3 months, N (%) 104 (50) 101 (50) 102 (50)
 Joint with knee pain*, n (%)
  Left knee only 30 (29) 31 (31) 29 (28)
  Right knee only 35 (34) 32 (32) 36 (35)
  Both knees 39 (38) 38 (38) 37 (36)
 Self-reported knee pain (NRS) 4.5 (2.0) 4.3 (2.3) 4.6 (2.2)
 Self-reported physical function (NRS) 3.9 (2.5) 3.9 (2.7) 4.3 (2.5)
Regular pain relief for musculoskeletal condition, N (%) 62 (30) 55 (27) 68 (33)
Ability to read and understand written health information#, median (IQR) 4.0 (4.0–5.0) 4.0 (4.0–5.0) 4.0 (4.0–5.0)

IQR, interquartile range (25th to 75th percentile); kg, kilograms; m, metres; NRS, numerical rating scale ranging from 0 (“no pain” or “no interference”) to 10 (“worst pain possible” or “maximal interference with function”).

* The denominator for joint with knee pain was the number of participants with knee pain in each group.

# Rated using a 5-point scale with terminal descriptors of 1 = “always difficult” to 5 = “always easy.”

Primary pair-wise comparisons: Primary outcomes

Compared to clinical explanation (no X-rays), those who received radiographic explanation (showing X-ray images) believed joint replacement surgery was more necessary (mean difference 1.1 NRS units [Bonferroni-adjusted 95% CI: 0.5, 1.8]; p < 0.001; Table 3), which exceeded our a priori minimum difference of 1-unit. This outcome did not differ between radiographic explanation with and without showing X-ray images. We did not observe any pair-wise differences in beliefs about the helpfulness of exercise and physical activity.

Table 3. Summary measures and estimated between-group mean differences [95% CI] for primary and secondary outcomes using complete case data.

Post-intervention, mean (SD) Between-group difference in post-intervention scores
Group 1 Group 2 Group 3 Primary comparison 1
Group 3 vs. 1
Primary comparison 2
Group 3 vs. 2
Secondary comparison
Group 2 vs. 1
Clinical explanation (no X-rays) [N = 208]a Radiographic explanation (not showing X-ray images) [N = 203]a Radiographic explanation (showing X-ray images) [N = 206]a Estimateb
(95% CI)c
P-valuec Estimateb
(95% CI)c
P-valuec Estimateb (95% CI) P-value
Primary outcomes
Belief joint replacement surgery is necessary at some stage* 3.3 (2.7) 3.9 (2.6) 4.5 (2.7) 1.1 (0.5, 1.8) <0.001 0.5 (−0.1, 1.2) 0.206 0.6 (0.1, 1.1) 0.020
Belief exercise and physical activity is helpful¥ 7.9 (1.9) 7.7 (2.0) 7.5 (2.2) −0.4 (−0.9, 0.1) 0.116 −0.2 (−0.7, 0.3) 1.370 −0.2 (−0.6, 0.1) 0.205
Secondary outcomes
Belief exercise would damage kneeβ 3.7 (2.5) 3.9 (2.5) 4.4 (2.4) 0.6 (0.2, 1.1) 0.008 0.4 (−0.1, 0.9) 0.083 0.2 (−0.3, 0.7) 0.355
Belief medication is helpful¥ 7.6 (2.0) 7.4 (1.9) 7.3 (2.0) −0.2 (−0.6, 0.2) 0.253 −0.1 (−0.5, 0.3) 0.622 −0.1 (−0.5, 0.3) 0.512
Level of concern§ 4.8 (2.5) 5.5 (2.4) 5.8 (2.5) 1.0 (0.5, 1.5) <0.001 0.3 (−0.2, 0.8) 0.232 0.7 (0.2, 1.2) 0.003
Fear of movement£ 13.0 (3.4) 13.6 (3.3) 14.0 (3.7) 1.0 (0.3, 1.7) 0.005 0.5 (−0.2, 1.1) 0.187 0.6 (−0.1, 1.2) 0.095
Belief about helpfulness of orthopaedic surgeon 5.1 (2.9) 6.4 (2.4) 6.4 (2.4) 1.3 (0.8, 1.8) <0.001 0.0 (−0.5, 0.4) 0.928 1.3 (0.8, 1.8) <0.001
Belief about helpfulness of rheumatologist 5.3 (2.9) 6.0 (2.3) 6.0 (2.4) 0.8 (0.2, 1.3) 0.004 0.1 (−0.4, 0.5) 0.804 0.7 (0.2, 1.2) 0.007
Belief about helpfulness of physiotherapist 6.6 (2.5) 7.0 (1.9) 7.2 (1.9) 0.6 (0.1, 1.0) 0.009 0.2 (−0.2, 0.5) 0.373 0.4 (0.0, 0.8) 0.070
Overall satisfaction with consultationα 7.5 (2.0) 7.7 (1.9) 7.9 (1.6) 0.4 (0.1, 0.8) 0.023 0.2 (−0.1, 0.6) 0.224 0.2 (−0.2, 0.6) 0.296
Satisfaction with information providedα 7.6 (2.0) 7.8 (1.7) 8.0 (1.5) 0.4 (0.0, 0.7) 0.033 0.2 (−0.1, 0.5) 0.193 0.2 (−0.2, 0.5) 0.380
Confidence in accuracy of diagnosisπ 7.3 (2.1) 7.8 (1.7) 8.0 (1.6) 0.6 (0.3, 1.0) 0.001 0.1 (−0.2, 0.5) 0.423 0.5 (0.1, 0.9) 0.011

CI, confidence interval; SD, standard deviation.

Positive between-group differences indicate higher score in: Group 3 (for Group 3 vs. 1 and Group 3 vs. 2); Group 2 (for Group 2 vs. 1).

a Five participants missing all primary and secondary outcomes (3 in Group 1, 1 in Group 2, and 1 in Group 3).

b Mean difference (95% CI) in post-intervention scores between groups, adjusted for the stratification factor lived experience with knee pain, estimated using separate linear regression models for each outcome.

c For the primary comparisons of the primary outcomes, two-sided 95% CIs and p-values were multiplicity adjusted (alpha = 0.0125).

* Measured using the 11-point numerical rating scale ranging from 0 = “definitely not necessary” to 10 = “definitely necessary.”

¥ Measured using the 11-point numerical rating scale ranging from 0 = “definitely not helpful” to 10 = “definitely helpful.”

β Measured using the 11-point numerical rating scale ranging from 0 = “definitely would not damage it” to 10 = “definitely would damage it.”

§ Measured using the 11-point numerical rating scale ranging from 0 = “not concerned” to 10 = “very concerned.”

£ Measured using the Brief Fear of Movement Scale. Scores range 6–24. Higher scores indicate greater fear of movement.

Measured using the 11-point numerical rating scale ranging from 0 = “definitely could not help” to 10 = “definitely could help.”

α Measured using the 11-point numerical rating scale ranging from 0 = “definitely not satisfied” to 10 = “definitely satisfied.”

π Measured using the 11-point numerical rating scale ranging from 0 = “not at all confident” to 10 = “very confident.”

Primary pair-wise comparisons: Secondary outcomes

Compared to clinical explanation (no X-rays), those who received radiographic explanation (showing X-ray images) believed exercise and physical activity was more damaging (0.6 [95% CI: 0.2, 1.1]; p = 0.008; Table 3), were more concerned about their knee problem getting worse (1.0 [0.5, 1.5]; p = p < 0.001), and had greater fear of movement (1.0 [0.3, 1.7]; p = 0.005). Participants who received radiographic explanation (showing X-ray images) also believed an orthopaedic surgeon (1.3 [0.8, 1.8]; p < 0.001) rheumatologist (0.8 [0.2, 1.3]; p = 0.004) and physiotherapist (0.6 [0.1, 1.0]; p = 0.009) would be more helpful, were more satisfied with the consultation (0.4 [0.1, 0.8]; p = 0.023), were more satisfied with the information provided by the GP (0.4 [0.0, 0.7]; p = 0.033), and were more confident in the accuracy of their diagnosis (0.6 [0.3, 1.0]; p = 0.001) than those who received clinical explanation (no X-rays). There were no differences in any secondary outcome when comparing radiographic explanation with and without showing X-ray images.

Secondary pair-wise comparisons

Compared to clinical explanation (no X-rays), those who received radiographic explanation (not showing X-ray images) believed joint replacement surgery was more necessary (0.6 [0.1, 1.1]; p = 0.020; Table 3), were more concerned about their knee problem getting worse (0.7 [0.2, 1.2]; p = 0.003), believed an orthopaedic surgeon (1.3 [0.8, 1.8]; p < 0.001) and rheumatologist (0.7 [0.2, 1.2]; p = 0.007) would be more helpful, and were more confident in the accuracy of the diagnosis (0.5 [0.1, 0.9]; p = 0.011).

Subgroup analyses

There were no differences in outcomes between participants with and without recent lived experience of knee pain (S8 Appendix).

Process measures

Most (99%) participants believed the video and audio quality was sufficient (S9 Appendix). Participants spent a median (interquartile range) of 2.2 (2.1 to 2.4) min watching the videos.

Discussion

We evaluated the effects of a radiographic knee OA diagnosis and explanation delivered by a GP on participant beliefs about osteoarthritis management, compared to a clinical explanation that did not use X-rays as the basis of diagnosis. We found that using X-rays increased participant beliefs that joint replacement surgery was necessary, but made no difference to beliefs about the helpfulness of exercise and physical activity. We also found that there were no differences in beliefs when explaining radiographic report findings with and without showing the X-ray images.

Our work provides, to our knowledge, the first causal evidence that using X-rays rather than a clinical approach to diagnose and explain knee OA can have potentially undesirable impacts on patient beliefs about knee OA. Prior qualitative research found that people with OA who receive X-rays of their joint believe that they need to protect it from further damage [21,24,36]. Our work also agrees with prior research showing that people who are given pathoanatomical OA educational information have unfavourable beliefs about OA and its management [15,28,29,33,37]. For participants in our study, receiving an X-ray–based diagnosis and explanation of knee OA may have reinforced existing misconceptions about OA given by the prevailing pathoanatomical discourse in current consumer OA information, which often employs biomedical terminology (e.g., “cartilage degeneration,” “bony spurs”) and visual representations that depict the joint as “damaged” [30,3841]. Our findings in knee OA align with research in low back pain. An RCT utilising a hypothetical scenario in low back pain found that a diagnosis and explanation based on magnetic resonance imaging worsened perceptions of back pain severity and fear of movement compared to a diagnosis and explanation not based on imaging [42]. Collectively, these findings may help to increase our understanding of why joint replacement surgery is overused and exercise and physical activity underused in management of knee OA [8].

Although a clinical diagnosis and explanation of knee OA led to potentially more favourable beliefs about OA management, we found that people who received a radiographic diagnosis and explanation were slightly more satisfied with their hypothetical GP consultation and the information provided, and were more confident in the accuracy of the diagnosis. This suggests that people with knee pain expect, and are re-assured, by diagnostic knee radiographs, even when the GP explains that X-ray findings are not necessarily related to knee pain nor predict prognosis. Our recent RCT evaluating different diagnostic labels for persistent hip pain also found that people were more satisfied with a label and explanation that included a description of pathoanatomical changes within the joint [28]. Collectively, these findings may suggest that people with joint pain attribute their pain to structural pathology and desire a biomedical explanation of the cause of their pain [4345]. Future research should explore ways in which an OA diagnosis and explanation can be conveyed in a manner that supports favourable patient attitudes towards OA, while also satisfying patient expectations for biomedical diagnostic information. Our findings contrast to those in low back pain [42], where participants were more satisfied with a diagnosis that did not rely on imaging. This may be because that study’s non-imaging intervention included other elements of best practice care (e.g., information about expectations for recovery, reassurance to reduce concern, and guidance to assist return to usual activity) which were not part of the experimental group that received an imaging-based diagnosis [42].

The magnitude of our between-group differences are similar to those observed in other RCTs utilising hypothetical situations and similar outcomes in OA [28,29,33,46] and other musculoskeletal conditions [26,27,31]. Many of our between-group differences met or exceeded the a priori 1-unit difference we aimed to detect, representing a 10% change in the NRS scale range (which has been suggested to be clinically important for other outcomes on 11-point NRS scales, such as pain intensity [47]). However, it is not clear whether these differences translate to changes in behaviour and improved health outcomes.

Our findings provide empirical evidence of the potential undesirable effects of using X-rays to diagnose and explain OA (S11 Appendix). Clinical guidelines and care standards advocate against routine use of imaging for diagnosing OA because there is no evidence it is beneficial for diagnosis [6,18,48], instead, recommending that healthcare providers diagnose knee OA clinically whenever possible [18]. However, trends in use of imaging for knee OA in Australia, the UK, and US have remained largely unchanged over time [8,19,48]. In the UK, knee radiographs have been ranked as one of the most overused tests in primary care [49]. In the US, X-rays are used for diagnosis of OA in 87% of patients presenting to primary care [19] and in Australia, 46% and 56% of patients presenting to a general practitioner for management of knee or hip OA respectively are referred for imaging [8]. It is thus not surprising that qualitative research in Australia has shown that most general practitioners prefer to use imaging to confirm a knee OA diagnosis, and that they describe OA to their patients as a problem of cartilage degeneration, joint space narrowing on X-ray, or “wear and tear” [22]. When general practitioners do provide a diagnosis of OA, they often avoid the term OA in favour of “wear and tear” [50] or use terms taken directly from radiology reports [51], which can convey a range of negative meanings to patients [52].

General practitioners may decide to order imaging for numerous reasons, including lack of time to discuss the risks and potential harms of imaging versus benefits, concern about malpractice, a desire to meet patient expectations, perceived need to exclude other diagnoses, or lack of confidence to diagnose OA without X-ray [22,53]. Changing clinical practice will require a substantial shift in long-held beliefs and habits [22] and our findings are a first step by showing that use of X-rays to diagnose and explain knee OA causally impacts patient beliefs about OA management. If X-ray is necessary, strategies to reduce potentially undesirable effects on patient beliefs may include reassuring patients that pathoanatomical changes do not necessarily predict prognosis and adapting the language and terminology used in X-ray reports (e.g., including epidemiological information about age-relevant prevalence of imaging characteristics in asymptomatic individuals) [42,54,55].

Our study has limitations. Participants with and without knee pain were asked to respond to a hypothetical scenario. While we found no moderating effect of the lived experience of recent knee pain on outcomes, our findings may not necessarily translate to real-world clinical situations. Although many outcomes met or exceeded our a priori minimal 1.0-unit difference immediately after watching the videos, it is unclear whether these effects on patient beliefs would impact their subsequent OA treatment. As we included only people who spoke and read English and those who had never previously consulted a clinician for chronic knee pain, our findings may not be generalisable to non-English speaking people or those who have sought care for chronic knee pain.

Conclusion

An X-ray–based diagnosis and explanation of knee osteoarthritis may have potentially undesirable effects on people’s beliefs about management.

Supporting information

S1 Appendix. Trial protocol.

(DOCX)

pmed.1004537.s001.docx (3.2MB, docx)
S2 Appendix. CONSORT checklist.

(DOCX)

pmed.1004537.s002.docx (27.9KB, docx)
S3 Appendix. Statistical analysis plan.

(DOCX)

pmed.1004537.s003.docx (3.1MB, docx)
S4 Appendix. Baseline descriptive demographic measures.

(DOCX)

pmed.1004537.s004.docx (2.6MB, docx)
S5 Appendix. Hypothetical scenario participants were asked to consider before being randomised to a group.

(DOCX)

pmed.1004537.s005.docx (2.6MB, docx)
S6 Appendix. Primary and secondary outcomes and process measures.

(DOCX)

pmed.1004537.s006.docx (20.2KB, docx)
S7 Appendix. Baseline characteristics of participants who did and did not complete at least one primary outcome, reported as mean (standard deviation) unless otherwise stated.

(DOCX)

pmed.1004537.s007.docx (18.7KB, docx)
S8 Appendix. Moderation of intervention effect by lived experience of knee pain on primary outcomes using complete case data.

(DOCX)

pmed.1004537.s008.docx (17.2KB, docx)
S9 Appendix. Process measures.

(DOCX)

pmed.1004537.s009.docx (14.7KB, docx)
S10 Appendix. X-ray images shown in the radiographic explanation (showing X-rays) group.

(DOCX)

pmed.1004537.s010.docx (627.4KB, docx)
S11 Appendix. Summary of key findings and implications for clinical practice.

(TIF)

pmed.1004537.s011.tif (557.1KB, tif)
S1 Video. Clinical explanation (no X-rays).

(MP4)

Download video file (37.2MB, mp4)
S2 Video. Radiographic explanation (not showing X-ray images).

(MP4)

Download video file (36.9MB, mp4)
S3 Video. Radiographic explanation (showing images).

(MP4)

Download video file (33.2MB, mp4)

Acknowledgments

Mr. Alexander Kimp for filming and editing the intervention videos.

Abbreviations

GP

general practitioner

NRS

numeric rating scale

OA

osteoarthritis

RCT

randomised controlled trial

SD

standard deviation

Data Availability

Data are available on figshare (https://doi.org/10.6084/m9.figshare.28216649).

Funding Statement

This study was supported by the National Health & Medical Research Council (Investigator Grant #2025733 to RSH). KLB, MH, and SF are supported by National Health & Medical Research Council Investigator grants (#1174431, #1172928, and #1194428, respectively). BJL is supported by an Arthritis Australia Fellowship (number not assigned). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–1330. doi: 10.1136/annrheumdis-2013-204763 [DOI] [PubMed] [Google Scholar]
  • 2.Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. EClinicalMedicine. 2020;29:100587. doi: 10.1016/j.eclinm.2020.100587 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol. 2020;72(2):149–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bannuru R, Osani M, Vaysbrot E, Arden N, Bennell K, Bierma-Zeinstra S, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthr Cartil. 2019;27(11):1578–1589. doi: 10.1016/j.joca.2019.06.011 [DOI] [PubMed] [Google Scholar]
  • 5.The Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis East Melbourne, VIC: RACGP; 2018. https://www.racgp.org.au/clinical-resources/clinical-guidelines/key-racgp-guidelines/view-all-racgp-guidelines/knee-and-hip-osteoarthritis.
  • 6.National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management London 2022. http://www.nice.org.uk/Guidance/CG177. [PubMed]
  • 7.Baumbach L, Roos EM, Lykkegaard J, Thomsen KS, Kristensen PL, Christensen AI, et al. Patients with osteoarthritis are least likely to receive lifestyle advice compared with patients with diabetes and hypertension: a national health survey study from Denmark. Osteoarthritis Cartilage Open. 2020;2(3):100067. doi: 10.1016/j.ocarto.2020.100067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bennell KL, Bayram C, Harrison C, Brand C, Buchbinder R, Haas R, et al. Trends in management of hip and knee osteoarthritis in general practice in Australia over an 11-year window: a nationwide cross-sectional survey. Lancet Reg Health West Pac. 2021;12:100187. doi: 10.1016/j.lanwpc.2021.100187 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Lam V, Teutsch S, Fielding J. Hip and knee replacements: a neglected potential savings opportunity. JAMA. 2018;319(10):977–978. doi: 10.1001/jama.2018.2310 [DOI] [PubMed] [Google Scholar]
  • 10.Bedenbaugh AV, Bonafede M, Marchlewicz EH, Lee V, Tambiah J. Real-world health care resource utilization and costs among US patients with knee osteoarthritis compared with controls. ClinicoEcon Outcomes Res. 2021;May 21(13):421–35. doi: 10.2147/CEOR.S302289 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg. 2007;89(4):780–785. doi: 10.2106/JBJS.F.00222 [DOI] [PubMed] [Google Scholar]
  • 12.Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan J, Protheroe J, Jordan K. Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthr Cartil. 2015;23(4):507–515. doi: 10.1016/j.joca.2014.11.019 [DOI] [PubMed] [Google Scholar]
  • 13.Jinks C, Botto-van Bemden A, Bunzli S, Bowden J, Egerton T, Eyles J, et al. Changing the narrative on osteoarthritis: A call for global action. Osteoarthr Cartil. 2024;32(4):414–420. [DOI] [PubMed] [Google Scholar]
  • 14.Zhang W, Doherty M, Peat G, Bierma-Zeinstra MA, Arden NK, Bresnihan B, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2010;69(3):483–489. doi: 10.1136/ard.2009.113100 [DOI] [PubMed] [Google Scholar]
  • 15.Bunzli S, O’Brien P, Ayton D, Dowsey M, Gunn J, Choong P, et al. Misconceptions and the acceptance of evidence-based nonsurgical interventions for knee osteoarthritis. A qualitative study. Clin Orthop Relat Res. 2019;477(9):1975. doi: 10.1097/CORR.0000000000000784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27(6):1513–1517. [PubMed] [Google Scholar]
  • 17.Kinds MB, Welsing PM, Vignon EP, Bijlsma JW, Viergever MA, Marijnissen AC, et al. A systematic review of the association between radiographic and clinical osteoarthritis of hip and knee. Osteoarthr Cartil. 2011;19(7):768–778. doi: 10.1016/j.joca.2011.01.015 [DOI] [PubMed] [Google Scholar]
  • 18.Australian Commission on Safety and Quality in Health Care. Osteoarthritis of the Knee: Clinical Care Standard Sydney, NSW, Australia2024. https://www.safetyandquality.gov.au/sites/default/files/2024-08/osteoarthritis-knee-clinical-care-standard-2024.pdf.
  • 19.Nalamachu S, Robinson RL, Viktrup L, Cappelleri JC, Bushmakin AG, Tive L, et al. Pain severity and healthcare resource utilization in patients with osteoarthritis in the United States. Postgrad Med. 2021;133(1):10–19. doi: 10.1080/00325481.2020.1841988 [DOI] [PubMed] [Google Scholar]
  • 20.Battista S, Manoni M, Dell’Isola A, Englund M, Palese A, Testa M. Giving an account of patients’ experience: A qualitative study on the care process of hip and knee osteoarthritis. Health Expect. 2022;25(3):1140–1156. doi: 10.1111/hex.13468 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Darlow B, Brown M, Thompson B, Hudson B, Grainger R, McKinlay E, et al. Living with osteoarthritis is a balancing act: an exploration of patients’ beliefs about knee pain. BMC Rheumatol. 2018;2(1):1–9. doi: 10.1186/s41927-018-0023-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Egerton T, Nelligan RK, Setchell J, Atkins L, Bennell KL. General practitioners’ views on managing knee osteoarthritis: a thematic analysis of factors influencing clinical practice guideline implementation in primary care. BMC Rheumatol. 2018;2(1):30. doi: 10.1186/s41927-018-0037-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Plante J, Kucksdorf J, Ruzich J, Young JL, Rhon DI. Do maladaptive imaging beliefs predict self-reported pain interference and physical function in patients with musculoskeletal disorders? J Orthop Sports Phys Ther. 2024;54(9):1–31. doi: 10.2519/jospt.2024.12625 [DOI] [PubMed] [Google Scholar]
  • 24.Haber T, Hinman RS, Dobson F, Bunzli S, Hilton A, Hall M. Peoples’ beliefs about their chronic hip pain and its care: a systematic review of qualitative studies. “I’m just getting old and breaking down”. Pain. 2023;164(5):926–947. [DOI] [PubMed] [Google Scholar]
  • 25.Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. doi: 10.1136/bmj.c869 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.O’Keeffe M, Ferreira GE, Harris IA, Darlow B, Buchbinder R, Traeger AC, et al. Effect of diagnostic labelling on management intentions for non-specific low back pain: a randomised scenario-based experiment. Eur J Pain. 2022;26(7):1532–1545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zadro JR, O’Keeffe M, Ferreira GE, Haas R, Harris IA, Buchbinder R, et al. Diagnostic labels for rotator cuff disease can increase people’s perceived need for shoulder surgery: an online randomized controlled trial. J Orthop Sports Phys Ther. 2021;51(8):401–411. doi: 10.2519/jospt.2021.10375 [DOI] [PubMed] [Google Scholar]
  • 28.Haber T, Hall M, Dobson F, Lawford BJ, McManus F, Lamb KE, et al. Effects of Hip Pain Diagnostic Labels and Their Explanations on Beliefs About Hip Pain and How to Manage It: An Online Randomized Controlled Trial. J Orthop Sports Phys Ther. 2023;53(11):673–684. doi: 10.2519/jospt.2023.11984 [DOI] [PubMed] [Google Scholar]
  • 29.Lawford BJ, Bennell KL, Hall M, Egerton T, Filbay S, McManus F, et al. Removing Pathoanatomical Content From Information Pamphlets About Knee Osteoarthritis Did Not Affect Beliefs About Imaging or Surgery, but Led to Lower Perceptions That Exercise Is Damaging and Better Osteoarthritis Knowledge: An Online Randomised Controlled Trial. J Orthop Sports Phys Ther. 2023;53(4):1–15. doi: 10.2519/jospt.2022.11618 [DOI] [PubMed] [Google Scholar]
  • 30.Arthritis Australia. Osteoarthritis. 2022. https://arthritisaustralia.com.au/types-of-arthritis/osteoarthritis/.
  • 31.Sharma S, Traeger AC, O’Keeffe M, Copp T, Freeman A, Hoffmann T, et al. Effect of information format on intentions and beliefs regarding diagnostic imaging for non-specific low back pain: A randomised controlled trial in members of the public. Patient Educ Couns. 2020;104(3):595–602. doi: 10.1016/j.pec.2020.08.021 [DOI] [PubMed] [Google Scholar]
  • 32.Shelby RA, Somers TJ, Keefe FJ, DeVellis BM, Patterson C, Renner JB, et al. Brief Fear of Movement Scale for osteoarthritis. Arthritis Care Res (Hoboken). 2012;64(6):862–871. doi: 10.1002/acr.21626 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lawford B, Bennel KL, Hall M, Egerton T, McManus FJ, Lamb KE, et al. Effect of information content and general practitioner recommendation on treatment beliefs and intentions for knee osteoarthritis: An online multi-arm randomised controlled trial. ACR Open. Rheumatology. 2023;5(1):17–27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.StataCorp. Stata Statistical Software: Release 17. College Station, TX: StataCorp LLC; 2021.
  • 35.Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond “p< 0.05”. Taylor & Francis; 2019.
  • 36.Bunzli S, Taylor N, O’Brien P, Dowsey M, Wallis J, Choong P, et al. How do people communicate about knee osteoarthritis? A Discourse Analysis. Pain Med. 2021;22(5):1127–1148. doi: 10.1093/pm/pnab012 [DOI] [PubMed] [Google Scholar]
  • 37.Barker KL, Reid M, Minns Lowe CJ. What does the language we use about arthritis mean to people who have osteoarthritis? A qualitative study. Disabil Rehabil. 2014;36(5):367–372. doi: 10.3109/09638288.2013.793409 [DOI] [PubMed] [Google Scholar]
  • 38.Arthritis Society. Osteoarthritis. 2022. https://arthritis.ca/about-arthritis/arthritis-types-(a-z)/types/osteoarthritis.
  • 39.Versus Arthritis. Osteoarthritis. 2022. https://www.versusarthritis.org/about-arthritis/conditions/osteoarthritis/.
  • 40.Arthritis Foundation. Osteoarthritis 2022. https://www.arthritis.org/diseases/osteoarthritis.
  • 41.Goff AJ, Barton CJ, Merolli M, Zhang Quah AS, Ki-Cheong Hoe C, De Oliveira SD. Comprehensiveness, accuracy, quality, credibility and readability of online information about knee osteoarthritis. Health Inf Manag J. 2022:18333583221090579. doi: 10.1177/18333583221090579 [DOI] [PubMed] [Google Scholar]
  • 42.Karran EL, Medalian Y, Hillier SL, Moseley GL. The impact of choosing words carefully: an online investigation into imaging reporting strategies and best practice care for low back pain. PeerJ. 2017;5:e4151. doi: 10.7717/peerj.4151 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Barber P, Lack SD, Bartholomew C, Curran AJ, Lowe CM, Morrissey D, et al. Patient experience of the diagnosis and management of patellofemoral pain: A qualitative exploration. Musculoskelet Sci Pract. 2022;57:102473. doi: 10.1016/j.msksp.2021.102473 [DOI] [PubMed] [Google Scholar]
  • 44.Maxwell C, Robinson K, McCreesh K. Understanding shoulder pain: a qualitative evidence synthesis exploring the patient experience. Phys Ther. 2021;101(3):pzaa229. doi: 10.1093/ptj/pzaa229 [DOI] [PubMed] [Google Scholar]
  • 45.Slade SC, Kent P, Bucknall T, Molloy E, Patel S, Buchbinder R. Barriers to primary care clinician adherence to clinical guidelines for the management of low back pain: protocol of a systematic review and meta-synthesis of qualitative studies. BMJ Open. 2015;5(4):e007265. doi: 10.1136/bmjopen-2014-007265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Egerton T, Bennell KL, McManus F, Lamb KE, Hinman RS. Comparative effect of two educational videos on self-efficacy and kinesiophobia in people with knee osteoarthritis: An online randomised controlled trial. Osteoarthr Cartil. 2022;30(10):1398–1410. doi: 10.1016/j.joca.2022.05.010 [DOI] [PubMed] [Google Scholar]
  • 47.Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi: 10.1016/j.jpain.2007.09.005 [DOI] [PubMed] [Google Scholar]
  • 48.Henry-Blake C, Marshall M, Treadwell K, Parmar S, Higgs J, Edwards JJ, et al. The use of plain radiography in diagnosing osteoarthritis: A systematic review and time trend analysis. Musculoskelet. 2023;21(2):462–477. [DOI] [PubMed] [Google Scholar]
  • 49.O’Sullivan JW, Stevens S, Hobbs FR, Salisbury C, Little P, Goldacre B, et al. Temporal trends in use of tests in UK primary care, 2000–15: retrospective analysis of 250 million tests. BMJ. 2018;363(Nov 28):k4666. doi: 10.1136/bmj.k4666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Paskins Z, Sanders T, Hassell AB. Comparison of patient experiences of the osteoarthritis consultation with GP attitudes and beliefs to OA: a narrative review. BMC Fam Pract. 2014;15(1):1–10. doi: 10.1186/1471-2296-15-46 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Paskins Z, Sanders T, Croft PR, Hassell AB. The identity crisis of osteoarthritis in general practice: a qualitative study using video-stimulated recall. Ann Fam Med. 2015;13(6):537–544. doi: 10.1370/afm.1866 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Vennik J, Hughes S, Smith KA, Misurya P, Bostock J, Howick J, et al. Patient and practitioner priorities and concerns about primary healthcare interactions for osteoarthritis: A meta-ethnography. Patient Educ Couns. 2022;105(7):1865–1877. doi: 10.1016/j.pec.2022.01.009 [DOI] [PubMed] [Google Scholar]
  • 53.Sears ED, Caverly TJ, Kullgren JT, Fagerlin A, Zikmund-Fisher BJ, Prenovost K, et al. Clinicians’ perceptions of barriers to avoiding inappropriate imaging for low back pain—knowing is not enough. JAMA Intern Med. 2016;176(12):1866–1868. doi: 10.1001/jamainternmed.2016.6364 [DOI] [PubMed] [Google Scholar]
  • 54.Jarvik JG, Meier EN, James KT, Gold LS, Tan KW, Kessler LG, et al. The effect of including benchmark prevalence data of common imaging findings in spine image reports on health care utilization among adults undergoing spine imaging: a stepped-wedge randomized clinical trial. JAMA Netw Open. 2020;3(9):e2015713–e. doi: 10.1001/jamanetworkopen.2020.15713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Rajasekaran S, Dilip Chand Raja S, Pushpa BT, Ananda KB, Ajoy Prasad S, Rishi MK. The catastrophization effects of an MRI report on the patient and surgeon and the benefits of ‘clinical reporting’: results from an RCT and blinded trials. Eur Spine J. 2021;30(7):2069–2081. doi: 10.1007/s00586-021-06809-0 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Heather Van Epps

30 Sep 2024

Dear Dr Lawford,

Thank you for submitting your manuscript entitled "Effects of x-ray based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial." for consideration by PLOS Medicine.

Your manuscript has now been evaluated by the PLOS Medicine editorial staff as well as by an academic editor with relevant expertise, and I am writing to let you know that we would like to send your submission out for external peer review.

However, before we can send your manuscript to reviewers, we need you to complete your submission by providing the metadata that is required for full assessment. To this end, please login to Editorial Manager where you will find the paper in the 'Submissions Needing Revisions' folder on your homepage. Please click 'Revise Submission' from the Action Links and complete all additional questions in the submission questionnaire.

Please re-submit your manuscript within two working days, i.e. by October 2nd.

Login to Editorial Manager here: https://www.editorialmanager.com/pmedicine

Once your full submission is complete, your paper will undergo a series of checks in preparation for peer review. Once your manuscript has passed all checks it will be sent out for review.

Feel free to email me directly at hvanepps@plos.org if you have any queries relating to your submission.

Kind regards,

Heather Van Epps, PhD

Executive Editor

PLOS Medicine

Decision Letter 1

Heather Van Epps

12 Dec 2024

Dear Dr Lawford,

Many thanks for submitting your manuscript "Effects of x-ray based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial." (PMEDICINE-D-24-03202R1), and please accept my apology for the delay in contacting you with a decision. The paper has been reviewed by two subject experts and a statistician; their comments are included below and can also be accessed here: [LINK]

As you will see, the reviewers found the study interesting, but they raised a few questions and requested some clarification of some of the methodological details. After discussing the paper with the editorial team and an academic editor with relevant expertise, I'm pleased to invite you to revise the paper in response to the reviewers' comments. We plan to send the revised paper to some or all of the original reviewers, and we cannot provide any guarantees at this stage regarding publication.

When you upload your revision, please include a point-by-point response that addresses all of the reviewer and editorial points, indicating the changes made in the manuscript and either an excerpt of the revised text or the location (eg: page and line number) where each change can be found. Please also be sure to check the general editorial comments at the end of this letter and include these in your point-by-point response. When you resubmit your paper, please include a clean version of the paper as the main article file and a version with changes tracked as a marked-up manuscript. It may also be helpful to check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper.

In view of the upcoming holidays, we ask that you submit your revision by Monday, January 6th. However, if this deadline is not feasible, please contact me by email, and we can discuss a suitable alternative. Please also feel free to contact me directly with any questions (hvanepps@plos.org).

Kind regards,

Heather

Heather Van Epps, PhD

Executive Editor

PLOS Medicine

hvanepps@plos.org

-----------------------------------------------------------

Comments from the editors/academic editor:

1. We felt that the discussion could be expanded to further contextualize the findings relative to real-world clinical scenarios; for example, the scenario of GPs providing no clinical explanation to patients with knee OA (ie, radiographic explanation only) is not well-documented, and it would be useful cite any previous studies that address this (current citations focus more on prescription trends for imaging).

2. The current data availability statement does not comply with the PLOS Data Availability Policy (see http://journals.plos.org/plosmedicine/s/data-availability), which requires that all data underlying the study's findings be provided in a repository or as Supporting Information. For data residing with a third party, authors are required to provide instructions with contact information (web or email address) for obtaining the data. Please note that a study author cannot be the contact person for the data. PLOS journals do not allow statements supported by "data not shown" or "unpublished results." For such statements, authors must provide supporting data or cite public sources that include it.

3. Abstract: please include details of the planned statistical analyses (primary and secondary comparisons).

4. Please include the full recruitment dates (Month, Day, Year) in the Abstract, with beginning and ending dates.

5. We take an all-or-none approach to inclusion of secondary outcomes in the abstract. If you choose to include secondary outcomes, they must all be included (methods and findings) to avoid selective reporting. Given the large number of secondary outcomes, we prefer that the abstract be limited to the primary outcome (per CONSORT).

6. Methods: please check the URL provided for the SAP, as the link does not appear to be correct/functional.

7. Please consider moving Figure 2 to the supplement, as we were not convinced that this graphic adds to the numerical reporting of the outcomes (although it would be very useful for oral presentations).

8. When you submit your revision, please include the original protocol (uploaded as a supplemental file) and the SAP (if a separate document). It was an oversight that these documents were not requested prior to peer review.

-----------------------------------------------------------

Comments from the reviewers:

Reviewer #1: Statistical review

This paper reports a three-arm RCT comparing hypothetical consultation strategies for individuals with knee osteoarthritis. I found the study design to be an interesting approach to investigate beliefs. The statistical methods are suitable and are mostly well-reported. I had only some minor comments, provided below:

1. Abstract: it would be useful to clarify that the first outcome is also a 11 point NRS - at the moment it is not clear that this is the case and it could be that it's a binary outcome. Perhaps add 'both' before 'measured on' on line 51.

2. Abstract: I would recommend providing the mean NRS per group as well as the mean difference + confidence interval. I would also provide this for the exercise/physical activity outcome.

3. Abstract: given the number of secondary outcomes in the trial registration page, I would recommend either not reporting results of secondary outcomes in the abstract, or briefly mentioning them all e.g. 'no significant differences were found for other outcomes including…'.

4. Table 3: I would recommend reporting p-values to 2 significant figures or <0.001 (I think this is the PLOS guidance).

James Wason

Reviewer #2:

This is a really interesting study on the potential effect of radiographic diagnosis on patients' beliefs about the management of their knee OA. I commend the authors for undertaking a well-designed and well-reported study examining the differences between clinical and radiographic diagnoses (without and with showing x-rays) using a hypothetical scenario. I have only a few minor queries about this work.

1. I wondered if the authors had any information or indication on why people failed to complete the survey, as this was quite a large proportion? What implications could this have had on the findings of the trial?

2. Previous research in electronic health records databases has shown that lots of patients with knee pain don't get a diagnosis of knee OA at their first consultation for their knee pain/knee problem. In the trial, patients who had previously consulted for knee pain were understandably excluded from this trial; however, their experience may also be important to consider, and I feel this should be acknowledged.

3. Can the authors comment on the impact of negative social media and negative messages that still exist in society, such as 'wear and tear', and the role they may have played on the study participants' beliefs and the expectations that a joint replacement will be needed, in general, but also with reference to the those who received a radiographic diagnosis?

Reviewer #3:

This is a very interesting paper. In my opinion this is a well-conducted and thorough study. I have only minor points.

1. Abstract: Clearly written abstract, this highlights the study's main results. It probably won't fit to add the nuance of the third group.

2. Methods: As I understand correctly you used a company to recruit people. Do they get paid for filling in a survey?

3. The link to the SAP is not working.

4. In the text I do not read if the GP is the same in each video, I guess so, but it is not mentioned.

5. Results: Figure 1 is clear. I was confused about the text saying 617 participants were enrolled and 523 were excluded. May be rephrase a bit.

Any attachments provided with reviews can be seen via the following link: [LINK]

--------------------------------------------------------- ---

General editorial requests:

(Note: not all will apply to your paper, but please check each item carefully)

* We ask every co-author listed on the manuscript to fill in a contributing author statement, making sure to declare all competing interests. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. If new competing interests are declared later in the revision process, this may also hold up the submission. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. Please do not add or remove authors without first discussing this with the handling editor. You can see our competing interests policy here: http://journals.plos.org/plosmedicine/s/competing-interests.

* Please upload any figures associated with your paper as individual TIF or EPS files with 300dpi resolution at resubmission; please read our figure guidelines for more information on our requirements: http://journals.plos.org/plosmedicine/s/figures. While revising your submission, please upload your figure files to the PACE digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at PLOSMedicine@plos.org.

* We expect all researchers with submissions to PLOS in which author-generated code underpins the findings in the manuscript to make all author-generated code available without restrictions upon publication of the work. In cases where code is central to the manuscript, we may require the code to be made available as a condition of publication. Authors are responsible for ensuring that the code is reusable and well documented. Please make any custom code available, either as part of your data deposition or as a supplementary file. Please add a sentence to your data availability statement regarding any code used in the study, e.g. "The code used in the analysis is available from Github [URL] and archived in Zenodo [DOI link]" Please review our guidelines at https://journals.plos.org/plosmedicine/s/materials-software-and-code-sharing and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. Because Github depositions can be readily changed or deleted, we encourage you to make a permanent DOI'd copy (e.g. in Zenodo) and provide the URL.

* Please ensure that the study is reported according to the CONSORT guideline and include the completed CONSORT checklist (https://www.equator-network.org/reporting-guidelines/consort/) as Supporting Information. When completing the checklist, please use section and paragraph numbers, rather than page numbers. Please add the following statement, or similar, to the Methods: "This study is reported as per CONSORT guideline (S1 Checklist)."

FORMATTING - GENERAL

* Abstract: Please structure your abstract using the PLOS Medicine headings (Background, Methods and Findings, Conclusions). Please combine the Methods and Findings sections into one section.

* At this stage, we ask that you include a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract. Ideally each sub-heading should contain 2-3 single sentence, concise bullet points containing the most salient points from your study. In the final bullet point of 'What Do These Findings Mean?', please include the main limitations of the study in non-technical language. Please see our author guidelines for more information: https://journals.plos.org/plosmedicine/s/revising-your-manuscript#loc-author-summary.

* Please express the main results with 95% CIs as well as p values. When reporting p values please report as p<0.001 and where higher as the exact p value p=0.002, for example. Throughout, suggest reporting statistical information as follows to improve clarity for the reader "22% (95% CI [13%,28%]; p</=)". Please be sure to define all numerical values at first use.

* Please include page numbers and line numbers in the manuscript file. Use continuous line numbers (do not restart the numbering on each page).

* Please cite the reference numbers in square brackets. Citations should precede punctuation.

FIGURES AND TABLES

* Please provide titles and legends for all figures and tables (including those in Supporting Information files).

* Please define all abbreviations used in each figure/table (including those in Supporting Information files).

* Please consider avoiding the use of red and green in order to make your figure more accessible to those with color blindness.

SUPPLEMENTARY MATERIAL

* Please note that supplementary material will be posted as supplied by the authors. Therefore, please amend it according to the relevant comments outlined here.

* Please cite your Supporting Information as outlined here: https://journals.plos.org/plosmedicine/s/supporting-information

REFERENCES

* PLOS uses the numbered citation (citation-sequence) method and first six authors, et al.

* Please ensure that journal name abbreviations match those found in the National Center for Biotechnology Information (NCBI) databases (http://www.ncbi.nlm.nih.gov/nlmcatalog/journals), and are appropriately formatted and capitalised.

* Where website addresses are cited, please include the complete URL and specify the date of access (e.g. [accessed: 12/06/2023]).

* Please also see https://journals.plos.org/plosmedicine/s/submission-guidelines#loc-references for further details on reference formatting.

RCTs

* PLOS Medicine requires that all trials be prospectively registered in one of registries recognized by WHO. Please ensure that study registration details are included in the Methods section.

* Please structure the Methods section using the following sub-headings: Study design and participants, Randomization and masking, Procedures, Outcomes, Statistical analysis.

* Please ensure that all prespecified outcomes (primary, secondary, and exploratory) are listed in the Methods/Outcomes section and indicate whether there are outcomes that are not presented in the current report.

* Please specify the dates (Month Day, Year) during which study enrollment and follow up occurred.

* Please include absolute numbers wherever you report percentages; eg, n/N (%)

* Please present the safety data for the study including numbers of specific events and whether or not adverse events are thought to be related to treatment. AEs should be reported in the abstract, per CONSORT and CONSORT-Harms.

* Please ensure that all components of CONSORT are present in the manuscript, including how randomization was performed, allocation concealment, blinding of intervention, definition of lost to follow-up, power statement. As above, when completing the checklist, please use section and paragraph numbers, rather than page numbers.

* Please report your abstract according to CONSORT for abstracts, following the PLOS Medicine abstract structure (Background, Methods and Findings, Conclusions) https://www.equator-network.org/reporting-guidelines/consort-abstracts/

* In keeping with our commitment to Open Science, please include the study protocol document and analysis plan (including any amendments) as Supporting Information to be published with the manuscript if accepted.

* Please note that PLOS Medicine requires prospective, public registration of a data sharing plan (as part of mandatory clinical trials registration) for all clinical trials that began enrollment on or after January 1, 2019, in accordance with ICMJE requirements.

Decision Letter 2

Heather Van Epps

15 Jan 2025

Dear Dr. Lawford,

Thank you very much for re-submitting your revised manuscript "Effects of x-ray based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial." (PMEDICINE-D-24-03202R2).

I have discussed the paper with my colleagues and the academic editor, and we were happy with the revised submission and your responses to the reviewers’ comments. As such, we did not feel that a second round of peer review was necessary. I am pleased to say that provided the remaining editorial and production issues are dealt with we are planning to accept the paper for publication in the journal.

The remaining issues that need to be addressed are listed at the end of this email. Any accompanying reviewer attachments can be seen via the link below. Please take these into account before resubmitting your manuscript:

[LINK]

***Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.***

In revising the manuscript for further consideration, please ensure you address the specific points made by the editors. In your rebuttal letter you should indicate your response to the reviewers' and editors' comments and the changes you have made in the manuscript. Please submit a clean version of the paper as the main article file. A version with changes marked must also be uploaded as a marked up manuscript file.

Please also check the guidelines for revised papers at http://journals.plos.org/plosmedicine/s/revising-your-manuscript for any that apply to your paper. If you haven't already, we ask that you provide a short, non-technical Author Summary of your research to make findings accessible to a wide audience that includes both scientists and non-scientists. The Author Summary should immediately follow the Abstract in your revised manuscript. This text is subject to editorial change and should be distinct from the scientific abstract.

We ask every co-author listed on the manuscript to fill in a contributing author statement. If any of the co-authors have not filled in the statement, we will remind them to do so when the paper is revised. If all statements are not completed in a timely fashion this could hold up the re-review process. Should there be a problem getting one of your co-authors to fill in a statement we will be in contact. YOU MUST NOT ADD OR REMOVE AUTHORS UNLESS YOU HAVE ALERTED THE EDITOR HANDLING THE MANUSCRIPT TO THE CHANGE AND THEY SPECIFICALLY HAVE AGREED TO IT.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

Please note, when your manuscript is accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you've already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosmedicine@plos.org.

We expect to receive your revised manuscript within 1 week (Jan 22nd). Please email me directly (hvanepps@plos.org) if this deadline is not feasible and we can discuss a suitable alternative. Please also reach out with any questions or concerns.

Kind regards,

Heather

Heather Van Epps, PhD

Executive Editor

PLOS Medicine

plosmedicine.org

------------------------------------------------------------

Requests from Editors:

1. Abstract, line 45 (and author summary). Please consider replacing ‘considered’ with ‘were presented with’ (ie, “Participants were presented with a hypothetical scenario…”).

2. Abstract line 53-54. If you wish to include the secondary comparison (clinical explanation [no x-rays] versus radiographic explanation [not showing x-ray images]) in the methodology paragraph, you should report the corresponding outcomes. Alternatively, you can remove the secondary comparison from the abstract (per CONSORT).

3. Please add a sentence at the end of the Abstract/Methods and findings section indicating the main limitation(s) of the trial.

4. Please review your text for claims of novelty or primacy (e.g. 'for the first time') and either remove this language or include “to our knowledge”—for example in the author summary and Discussion, line 390. In addition, please check that any use of statistical terms (such as trend or significant) are supported by the data, and if not please remove them.

5. Please remove subheadings from the Discussion section, which should be presented as a continuous narrative.

6. Please include URLs for relevant references (eg, refs 5, 6, 18, etc).

7. Please ensure that the link to the Dryad Digital Repository is live when you submit the final revision.

8. Please modify the CONSORT checklist to use section and paragraph numbers, rather than page numbers.

9. Please upload the supplemental material as a separate file to the main manuscript.

10. In accordance with ICMJE requirements, PLOS Medicine requires prospective, public registration of a data sharing plan (as part of mandatory clinical trials registration) for all clinical trials that began enrollment on or after January 1, 2019.

Decision Letter 3

Heather Van Epps

20 Jan 2025

Dear Dr Lawford, 

On behalf of my colleagues and the Academic Editor, Christelle Nguyen, I am pleased to inform you that we have agreed to publish your manuscript "Effects of x-ray based diagnosis and explanation of knee osteoarthritis on patient beliefs about osteoarthritis management: A randomised clinical trial." (PMEDICINE-D-24-03202R3) in PLOS Medicine.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Once you have received these formatting requests, please note that your manuscript will not be scheduled for publication until you have made the required changes.

In the meantime, please log into Editorial Manager at http://www.editorialmanager.com/pmedicine/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production process. 

PRESS

We frequently collaborate with press offices. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximise its impact. If the press office is planning to promote your findings, we would be grateful if they could coordinate with medicinepress@plos.org. If you have not yet opted out of the early version process, we ask that you notify us immediately of any press plans so that we may do so on your behalf.

We also ask that you take this opportunity to read our Embargo Policy regarding the discussion, promotion and media coverage of work that is yet to be published by PLOS. As your manuscript is not yet published, it is bound by the conditions of our Embargo Policy. Please be aware that this policy is in place both to ensure that any press coverage of your article is fully substantiated and to provide a direct link between such coverage and the published work. For full details of our Embargo Policy, please visit http://www.plos.org/about/media-inquiries/embargo-policy/.

Thank you again for submitting to PLOS Medicine. We look forward to publishing your paper. 

Kind regards,

Heather

Heather Van Epps, PhD 

Executive Editor 

PLOS Medicine

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Trial protocol.

    (DOCX)

    pmed.1004537.s001.docx (3.2MB, docx)
    S2 Appendix. CONSORT checklist.

    (DOCX)

    pmed.1004537.s002.docx (27.9KB, docx)
    S3 Appendix. Statistical analysis plan.

    (DOCX)

    pmed.1004537.s003.docx (3.1MB, docx)
    S4 Appendix. Baseline descriptive demographic measures.

    (DOCX)

    pmed.1004537.s004.docx (2.6MB, docx)
    S5 Appendix. Hypothetical scenario participants were asked to consider before being randomised to a group.

    (DOCX)

    pmed.1004537.s005.docx (2.6MB, docx)
    S6 Appendix. Primary and secondary outcomes and process measures.

    (DOCX)

    pmed.1004537.s006.docx (20.2KB, docx)
    S7 Appendix. Baseline characteristics of participants who did and did not complete at least one primary outcome, reported as mean (standard deviation) unless otherwise stated.

    (DOCX)

    pmed.1004537.s007.docx (18.7KB, docx)
    S8 Appendix. Moderation of intervention effect by lived experience of knee pain on primary outcomes using complete case data.

    (DOCX)

    pmed.1004537.s008.docx (17.2KB, docx)
    S9 Appendix. Process measures.

    (DOCX)

    pmed.1004537.s009.docx (14.7KB, docx)
    S10 Appendix. X-ray images shown in the radiographic explanation (showing X-rays) group.

    (DOCX)

    pmed.1004537.s010.docx (627.4KB, docx)
    S11 Appendix. Summary of key findings and implications for clinical practice.

    (TIF)

    pmed.1004537.s011.tif (557.1KB, tif)
    S1 Video. Clinical explanation (no X-rays).

    (MP4)

    Download video file (37.2MB, mp4)
    S2 Video. Radiographic explanation (not showing X-ray images).

    (MP4)

    Download video file (36.9MB, mp4)
    S3 Video. Radiographic explanation (showing images).

    (MP4)

    Download video file (33.2MB, mp4)
    Attachment

    Submitted filename: PLOS Medicine response to reviewer comments_v1.docx

    pmed.1004537.s015.docx (77.6KB, docx)
    Attachment

    Submitted filename: PLOS Medicine response to reviewer comments_v2.docx

    pmed.1004537.s016.docx (45.4KB, docx)

    Data Availability Statement

    Data are available on figshare (https://doi.org/10.6084/m9.figshare.28216649).


    Articles from PLOS Medicine are provided here courtesy of PLOS

    RESOURCES